ID

34418

Descripción

Endostar Combination With Chemotherapy for the Metastatic Nasopharyngeal Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01612286

Link

https://clinicaltrials.gov/show/NCT01612286

Palabras clave

  1. 17/1/19 17/1/19 -
  2. 27/3/20 27/3/20 - Sarah Riepenhausen
Titular de derechos de autor

GSK group of companies

Subido en

17 de enero de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Nasopharyngeal Carcinoma NCT01612286

Eligibility Nasopharyngeal Carcinoma NCT01612286

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosed metastatic npc patient who have received radiotherapy or chemoradiotherapy with an at least 6 months interval
Descripción

ID.1

Tipo de datos

boolean

have measurable lesions
Descripción

ID.2

Tipo de datos

boolean

no dysfunction of the major organs
Descripción

ID.3

Tipo de datos

boolean

can understand this study and give a signed informed consent certificates
Descripción

ID.4

Tipo de datos

boolean

without a history of allergic reaction to the biological agents
Descripción

ID.5

Tipo de datos

boolean

Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnant or lactating women; women of child-bearing age without contraception
Descripción

ID.6

Tipo de datos

boolean

with a serious infection or dysfunction of the major organs
Descripción

ID.7

Tipo de datos

boolean

have taken other antitumor drugs during the period of 30 days ahead of this clinical trial
Descripción

ID.8

Tipo de datos

boolean

allergic to the escherichia coli preparations
Descripción

ID.9

Tipo de datos

boolean

cann't understand this study and give a signed informed consent certificates
Descripción

ID.10

Tipo de datos

boolean

Similar models

Eligibility Nasopharyngeal Carcinoma NCT01612286

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
diagnosed metastatic npc patient who have received radiotherapy or chemoradiotherapy with an at least 6 months interval
boolean
ID.2
Item
have measurable lesions
boolean
ID.3
Item
no dysfunction of the major organs
boolean
ID.4
Item
can understand this study and give a signed informed consent certificates
boolean
ID.5
Item
without a history of allergic reaction to the biological agents
boolean
Item Group
C0680251 (UMLS CUI)
ID.6
Item
pregnant or lactating women; women of child-bearing age without contraception
boolean
ID.7
Item
with a serious infection or dysfunction of the major organs
boolean
ID.8
Item
have taken other antitumor drugs during the period of 30 days ahead of this clinical trial
boolean
ID.9
Item
allergic to the escherichia coli preparations
boolean
ID.10
Item
cann't understand this study and give a signed informed consent certificates
boolean

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial